Alzheimer's disease symptoms more subtle in people over 80

September, 2011

A new study shows that, among the very old, it’s harder to distinguish between normal brain atrophy and cognitive impairment and that indicative of Alzheimer’s.

A study involving 105 people with Alzheimer's disease and 125 healthy older adults has compared cognitive function and brain shrinkage in those aged 60-75 and those aged 80+.

It was found that the association between brain atrophy and cognitive impairment typically found in those with Alzheimer’s disease was less evident in the older group. This is partly because of the level of brain atrophy in healthy controls in that age group — there was less difference between the healthy controls and those with Alzheimer’s. Additionally, when compared to their healthy counterparts, executive function, immediate memory and attention/processing speed were less abnormal in the older group than they were in the younger group.

The finding suggests that mild Alzheimer’s in the very old may go undetected, and emphasize the importance of taking age into account when interpreting test performance and brain measures.

http://www.eurekalert.org/pub_releases/2011-08/aaon-sad080211.php

Reference:

[2503] Stricker, N. H., Chang Y. - L., Fennema-Notestine C., Delano-Wood L., Salmon D. P., Bondi M. W., et al.
(2011). Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease.
Neurology. 77(8), 713 - 721.

seniors

Alzheimers

Related News

Controlling diabetes important for slowing cognitive decline

The latest finding from the large, long-running Health, Aging, and Body Composition (Health ABC) Study adds to the evidence that preventing or controlling diabetes helps prevent age-related cognitive decline.

Benefits of omega-3 in preventing age-related cognitive decline not proven

A review of three high quality trials comparing the putative benefits of omega-3 fatty acids for preventing age-related cognitive decline, has concluded that there is no evidence that taking fish oil supplements helps fight cognitive decline.

Alzheimer's risk gene disrupts brain function in older women, but not men

While the ‘Alzheimer’s gene’ is relatively common — the ApoE4 mutation is present in around 15% of the population — having two copies of the mutation is, thankfully, much rarer, at around 2%.

Brief questionnaire for dementia progression validated

Dementia is a progressive illness, and its behavioral and psychological symptoms are, for caregivers, the most difficult symptoms to manage.

Exercise reduces Alzheimer's damage in brain

A study designed to compare the relative benefits of exercise and diet control on Alzheimer’s pathology and cognitive performance has revealed that while both are beneficial, exercise is of greater benefit in reducing Alzheimer’s pathology and cognitive impairment.

Rapamycin makes young mice learn better and prevents decline in old mice

I have reported previously on research suggesting that rapamycin, a bacterial product first isolated from soil on Easter Island and used to help transplant patients prevent organ rejection, might improve learning and memory.

Coffee helps prevent progression to dementia

Following on from mouse studies, a human study has investigated whether caffeine can help prevent older adults with mild cognitive impairment from progressing to dementia.

Alzheimer’s biomarkers present decades before symptoms

A study involving those with a strong genetic risk of developing Alzheimer’s has found that the first signs of the disease can be detected 25 years before symptoms are evident.

Immune system may protect against Alzheimer's

A number of studies have come out in recent years linking age-related cognitive decline and dementia risk to inflammation and infection (put inflammation into the “Search this site” box at the top of the page and you’ll see what I mean). New research suggests one important mechanism.

Effect of blood pressure on the aging brain depends on genetics

I’ve reported before on the evidence suggesting that carriers of the ‘Alzheimer’s gene’, APOE4, tend to have smaller brain volumes and perform worse on cognitive tests, despite being cognitively ‘normal’.

Pages